TD Private Client Wealth’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91K | Sell |
253
-64
| -20% | -$989 | ﹤0.01% | 1140 |
|
|
2025
Q1 | $4.71K | Buy |
317
+79
| +33% | +$1.18K | ﹤0.01% | 1086 |
|
|
2024
Q4 | $3.15K | Hold |
238
| – | – | ﹤0.01% | 1140 |
|
|
2024
Q3 | $3.38K | Hold |
238
| – | – | ﹤0.01% | 1133 |
|
|
2024
Q2 | $3.08K | Buy |
238
+123
| +107% | +$1.59K | ﹤0.01% | 1116 |
|
|
2024
Q1 | $1.6K | Hold |
115
| – | – | ﹤0.01% | 1145 |
|
|
2023
Q4 | $1.64K | Hold |
115
| – | – | ﹤0.01% | 1165 |
|
|
2023
Q3 | $1.78K | Hold |
115
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q2 | $1.81K | Sell |
115
-87
| -43% | -$1.37K | ﹤0.01% | 1173 |
|
|
2023
Q1 | $3.33K | Sell |
202
-934
| -82% | -$15.4K | ﹤0.01% | 1128 |
|
|
2022
Q4 | $17.7K | Buy |
+1,136
| New | +$17.7K | ﹤0.01% | 932 |
|
|
2022
Q2 | – | Sell |
-472
| Closed | -$6.76K | – | 1293 |
|
|
2022
Q1 | $6.76K | Hold |
472
| – | – | ﹤0.01% | 1078 |
|
|
2021
Q4 | $6.43K | Sell |
472
-18,893
| -98% | -$257K | ﹤0.01% | 938 |
|
|
2021
Q3 | $317K | Sell |
19,365
-6,765
| -26% | -$111K | 0.01% | 463 |
|
|
2021
Q2 | $440K | Sell |
26,130
-615
| -2% | -$10.4K | 0.02% | 425 |
|
|
2021
Q1 | $488K | Buy |
26,745
+6,157
| +30% | +$112K | 0.02% | 395 |
|
|
2020
Q4 | $375K | Sell |
20,588
-958
| -4% | -$17.4K | 0.02% | 413 |
|
|
2020
Q3 | $384K | Sell |
21,546
-5,551
| -20% | -$99K | 0.02% | 387 |
|
|
2020
Q2 | $486K | Sell |
27,097
-1,716
| -6% | -$30.8K | 0.03% | 360 |
|
|
2020
Q1 | $437K | Buy |
28,813
+10,383
| +56% | +$158K | 0.03% | 339 |
|
|
2019
Q4 | $364K | Buy |
+18,430
| New | +$364K | 0.02% | 391 |
|